IXC.AX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 21:22):

Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury that has completed Phase II clinical trial...

Stats
Today's Volume	147 798
Average Volume	46 794.00
Market Cap	6.01M
EPS	$0 ( 2024-02-16 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.000
ATR14	$0 (0.00%)

Invex Therapeutics Ltd Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Invex Therapeutics Ltd Financials

Annual	2023
Revenue:	$459 085
Gross Profit:	$459 085 (100.00 %)
EPS:	$-0.100

FY	2023
Revenue:	$459 085
Gross Profit:	$459 085 (100.00 %)
EPS:	$-0.100

FY	2022
Revenue:	$182 251
Gross Profit:	$182 251 (100.00 %)
EPS:	$-0.0526

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.0407

Financial Reports:

No articles found.

Invex Therapeutics Ltd